Skip to main content
Erschienen in: Obesity Surgery 5/2007

Open Access 01.05.2007

Conversion of Vertical Banded Gastroplasty to Roux-en-Y Gastric Bypass Results in Restoration of the Positive Effect on Weight Loss and Co-morbidities: Evaluation of 101 Patients

verfasst von: Ruben Schouten, MD, Francois M. H. van Dielen, MD, PhD, Wim G. van Gemert, MD, PhD, Jan Willem M. Greve, MD, PhD

Erschienen in: Obesity Surgery | Ausgabe 5/2007

Background

Vertical banded gastroplasty (VBG) is a widely used restrictive procedure in bariatric surgery. However, the re-operation rate after this operation is high. In the case of VBG failure, a conversion to Rouxen-Y gastric bypass (RYGBP) is an option. A study was undertaken to evaluate the results of the conversion from VBG to RYGBP.

Methods

101 patients had conversion from VBG to RYGBP. Patients were separated into 3 groups, based on the indication for conversion: weight regain (group 1), excessive weight loss (group 2) and severe eating difficulties (group 3). Data for the study were collected by retrospective analysis of prospectively recorded data.

Results

Weight regain (group 1) was the reason for conversion in 73.3% of patients. Staple-line disruption was the most important cause for the weight regain (74.3%). Excessive weight loss (group 2) affected 14% of patients and was caused by outlet stenosis in 78.6% of patients. The remaining 13% had severe eating difficulties as a result of outlet stenosis (46.1%), pouch dilatation (30.8%) and pouch diverticula (23.1%). Mean BMI before conversion to RYGBP was 40.5, 22.3 and 29.8 kg/m2 in group 1, 2 and 3, respectively. Minor or major direct postoperative complications were observed in 2.0% to 7.0%. Long-term complications were more frequent, and consisted mainly of anastomotic stenosis (22.7%) and incisional hernia (16.8%). Follow-up after conversion was achieved in all patients (100%), with a mean period of 38 ±–9 months. BMI decreased from 40.5 to 30.1 kg/m2, increased from 22.3 to 25.3 kg/m2. and decreased slightly from 29.8 to 29.0 kg/m2 in group 1, 2 and 3, respectively. All patients in group 3 noticed an improvement in eating difficulties.

Conclusion

Complications after conversion from failed VBG to RYGBP are substantial and need to be considered. However, the conversion itself is a successful operation in terms of effect on body weight and treating eating difficulties after VBG.

Introduction

Morbid obesity is a rapidly growing problem in western society. In the United States, 2% of men and 6% of women are morbidly obese, and have a mortality rate up to 12 times greater compared to normal-weight individuals.1,2 In the Netherlands, the prevalence is less disturbing but the incidence of obesity and especially morbid obesity, defined as a body mass index (BMI) of >40 kg/m2 or >35 kg/m2 with obesity-related co-morbidities,3 is rising progressively to 1.5% of the total population in 2004.4
At this moment, surgical therapy is the only treatment option for these patients that results in sufficient long-term weight loss.5 Non-surgical approaches, like low energy diets and behavior modification, are not successful in the long-term with respect to maintaining weight loss and decreasing obesity-related co-morbidity.6
Gastric restrictive surgery was introduced in the mid-1970s in the form of transverse gastroplasty and has been developed and improved since.7 This procedure evolved to vertical banded gastroplasty (VBG) as described by Mason and others, and has been performed on thousands of patients worldwide.811 However, revisional surgery is often necessary after VBG, with reported percentages in the literature of 10% to 41%, mainly because of stoma stenosis, pouch enlargement and staple-line disruption.1216
In the case of VBG failure, conversion to another bariatric operation is a possibility. According to the available literature, conversion to Roux-en-Y gastric bypass (RYGBP) appears to have good results.1721 The present study was conducted in order to evaluate the mid-term results of the conversion from VBG to RYGBP.

Patients and Methods

Patients

Between April 1988 and January 2002, a total of 288 patients underwent a VBG in our clinic. All patients were between age 18 and 60 years at the time of operation and had failed previous non-surgical attempts to lose weight. Patients were considered eligible if the BMI was >40 kg/m2 or >35 kg/m2 with obesity-related co-morbidities. All patients treated by VBG were followed postoperatively. Between December 1996 and November 2005, a total of 101 patients had a conversion from VBG to RYGBP because of weight regain, excessive weight loss or severe eating difficulties. Thirteen patients from this group (12.9%) were referred from other hospitals. Failure rate after VBG in patients from our clinic was 30.6% (88 patients). Patient characteristics are listed in Table 1. The patient group consisted of 15 males and 86 females with a mean age of 40.0 ± 8.4 years. Mean weight and BMI before VBG was 137.0 ± 27.5 kg and 48.4 ± 7.7 kg/m2.
Table 1
Patient characteristics
Variables
Before VBG
Patients (N)
101
M : F
15 : 86
Age (years)
40.0 (26 – 64) ± 8.4
Weight (kg)
137.0 (90.0 – 229.5) ± 27.5
BMI (kg/m2)
48.4 (35.9 – 74.0) ± 7.7

Surgical Technique

The surgical technique of the VBG has previously been described in detail.9,10,17
RYGBP was performed through the old upper midline incision. The operative field was freed by sharp and blunt dissection, and the band was removed. In the case of staple-line disruption, the pouch was created with a diameter of 1 cm and a length of 5–6 cm. In other cases, the existing staple-line was transected after which the pouch was trimmed by resection of excess gastric tissue with a stapler device (GIA-60, Autosuture, Zeist, the Netherlands). The latter was done to prevent formation of an excluded segment of stomach which can result in a mucocele. In all cases, the gastric pouch was completely disconnected from the excluded stomach. Next, the jejunum was transected 40–60 cm distal to the ligament of Treitz. The staple-line of the long limb was reinforced with a running suture, and brought retrocolic and retrogastric to the gastric pouch. Through a small opening on the antimesenteric side, an end-to-side gastrojejunal anastomosis was created. The Roux-en-Y reconstruction was completed with an end-to-side jejunojejunal anastomosis 60–120 cm distal to the gastrojejunal anastomosis. To prevent herniation, all mesenteric defects were closed with a nonabsorbable suture. The abdominal wall was closed with a running nonabsorbable suture and the skin with staples. Due to a high anastomotic stenosis rate in patients operated before 2004, the operative technique was modified in that year, where instead of a small anastomosis, calibrated with a charriere 14 nasogastric tube, a wider anastomosis was calibrated with a charriere 32 tube. This widening of the anastomosis was performed in association with placement of a silastic ring of 6–6.5 cm in diameter 1 cm proximal to the gastrojejunostomy, as described by Fobi et al.22,23 The last 13 patients (12.9%) were operated according to this technique. Patients received intravenous prophylactic antibiotics and subcutaneous heparin. Vitamin A, B, D and iron supplementation were prescribed postoperatively.

Data Collection

Patients were seen on a regular basis at the outpatient clinic by the surgeon, nurse practitioner, dietician and psychologist. Necessary data for this study were collected by retrospective analysis of prospectively recorded data. In order to accomplish a complete database, questionnaires were sent to the patients to collect up-to-date information on body weight, co-morbidities, complications and symptoms. Presence and resolution of obesity-related co-morbodities were quantified by the use and discontinuation postoperatively of medication in the instance of diabetes, hypertension and hypercholesterolemia. Joint problems, asthma, gastroesophageal reflux disease (GERD) and depression were quantified by both history-taking and/or medication. The presence of preoperative sleep apnea syndrome was quantified by sleep studies in all patients, the resolution postoperatively by subjective improvement of sleep and daily drowsiness and the discontinuation of the use of CPAP masks.
Patients were categorized into three groups for analysis based on the indication for conversion: group 1 — weight regain after initially successful weight loss, group 2 — excessive weight loss leading to a BMI <25 with malnutrition (low albumin and total protein levels), and group 3 — severe eating difficulties (daily nausea, vomiting or pyrosis, dysphagia while eating and not existing preoperatively, continuous epigastric pain postoperatively not caused by other demonstrable problems except the operation, or daily passage problems with solid food). Despite these eating difficulties, patients from group 3 had an acceptable weight loss postoperatively.
The effect of the conversion on weight loss and co-morbidities was the main interest of the study. Furthermore, data were collected on the time between operations, operating time, hospital stay, perioperative and mid-term complications and reoperations performed during follow-up. All data are reported as mean ± standard deviation.

Results

Indications for Conversion

Patients were categorized into the three groups based on the indication for conversion (Table 2).
Table 2
Indication for conversion from VBG to RYGBP
Indication
Patients (%)
Group 1: weight gain
74 (73.3%)
Group 2: excessive weight loss
14 (13.9%)
Group 3 severe eating / outlet difficulties
13 (12.8%)

Group 1: Weight Regain

This group consisted of 74 patients (73.3%) with initially successful weight loss after VBG but weight regain during follow-up. Causes of this weight regain were mainly staple-line disruption (74.3%) and pouch dilatation (9.4%), defined as increased pouch size on upper GI series compared to the first postoperative GI series but without anastomotic stenosis. The size of the pouch was measured in relation to the vertebrae. Furthermore, four patients (5.4%) were sweets eaters. Infrequent causes were outlet stenosis (1.4%), complicated by pouch diverticula and resulting in intake of high caloric liquids, persistent retrosternal pain (1.4%) caused by anastomotic stenosis and solid food intolerance leading to change of eating habits (high caloric liquids), and a wide outlet of the pouch (1.4%); in 6.7% of patients, the cause remained unknown. All causes are summarized in Table 3-A.
Table 3-A
Causes of VBG failure
Group 1: weight regain (N = 74)
Cause
Patients (N)
Percentage (of group)
Percentage (of total)
(Staple-line disruption
55
74.3%
54.5%
Pouch dilatation
7
9.4%
6.9%
Sweets eater
4
5.4%
4.0%
Wide outlet
1
1.4%
1.0%
Pouch diverticula
1
1.4%
1.0%
Pain
1
1.4%
1.0%
Unknown
5
6.7%
5.0%

Group 2: Excessive Weight Loss

Fourteen patients (13.9%) had excessive weight loss after VBG, for which conversion to RYGBP was necessary in order to stabilize weight. The main cause for the excessive weight loss was outlet stenosis (78.6%). One patient (7.1%) had a pouch dilatation, while in two patients (14.3%) the cause was not established (Table 3-B).
Table 3-B
Causes of VBG failure
Group 2: excessive weight loss (N = 14)
Cause
Patients (N)
Percentage (of group)
Percentage (of total)
Outlet stenosis
11
78.6%
10.9%
Pouch formation
1
7.1%
1.0%
Unknown
2
14.3%
2.0%

Group 3: Severe Eating Difficulties

Thirteen patients (12.8%) developed severe eating difficulties during follow-up after VBG. The most frequent difficulties were passage problems of solid foods (100%), daily vomiting (92.3%) and pyrosis (76.9%). Weight loss was successful after VBG in this group, and conversion to RYGBP was performed in order to treat the symptoms. Causes of these severe eating difficulties were outlet stenosis (46.1%), pouch dilatation (30.8%) and pouch diverticula (23.1%) (Table 3-C).
Table 3-C
Causes of VBG failure
Group 3: severe eating problems (N = 13)
Cause
Patients (N)
Percentage (of group)
Percentage (of total)
Outlet stenosis
6
46.1%
6.0%
Pouch formation
4
30.8%
4.0%
Pouch diverticula
3
23.1%
3.0%

Operation and Hospitalization Details

Mean time between VBG and conversion to RYGBP was 62 ± 50 months for the total group (range 5 to 309 months). There were notable differences between the groups (Table 4). Mean time between the operations was shorter in group 2 with 30 ± 23 months compared with 65 ± 51 months in group 1 and 76 ± 50 months in group 3.
Table 4
RYGBP: operation details
 
Group 1
Group 2
Group 3
Total group
Time VBG − RYGBP (months)
65 ± 51
30 ± 23
76 ± 50
62 (5 − 309) ± 50
Operation time (hours)
3.7 ± 0.9
3.6 ± 0.7
3.4 ± 1.0
3.7 (1.9 − 6.8) ± 0.9
Cholecystectomy during RYGBP (N)
3
1
2
6 (5.9%)
Cholecystectomy during follow-up (N)
12
3
0
15 (14.9%)
Hospital stay (days)
10
24
8
12 (3 − 84)
Mean operating time was 3.7 ± 0.9 hours with a range from 1.9 to 6.8 hours. There were no significant differences between the groups. Cholecystectomy was performed in 6 patients (5.9%) during the same operative session. In another 15 patients (14.9%), cholecystectomy was performed during follow-up after RYGBP, all for symptomatic gallstones.
Mean hospital stay after RYGBP was 12 days, with a wide range of 3 to 84 days. Patients from group 2 were relatively malnourished before the conversion to RYGBP because of the excessive weight loss, and 5 patients (36%) received total parental nutrition for a mean of 10 days prior to surgery. Other patients had already started a high protein diet with vitamin and mineral supplements at home. As a result, the mean hospitalization was significantly longer in group 2 (24 days) compared to group 1 (10 days) and group 3 (8 days). Patients from group 2 (N=14) had varying dietary deficiencies preoperatively: albumin (10), iron (10), total protein (8), magnesium (6), vitamin B1 (4), B6 (3), folic acid (3), zinc (3), copper (1) and vitamin B12 (1). The conversion was performed as soon as these deficiencies were corrected.

Complications

Forty-five patients (44.6%) did not have any complications. Either direct postoperative and/or long-term complications occurred in 56 patients (55.4%). More than one complication occurred in 19 patients (18.8%).

Mortality.

Two patients died after conversion from VBG to RYGBP (2.0%). These two patients had weight regain after initially successful weight loss, for which a cause was not found. Both developed severe sepsis postoperatively, one due to leakage at the gastrojejunostomy and one due to a small bowel laceration probably brought on by release of adhesions.

Major Direct Postoperative Complications.

Anastomotic leakage, treated conservatively or operatively depending on the clinical condition, occurred in 2.0% and 4.0% of the patients respectively (Table 5). Intraabdominal abscess and internal hernia also occurred in 2.0% and 4.0%, respectively. Intraabdominal abscesses were treated by CT-guided percutaneous puncture and drainage. Internal herniation was treated during re-laparotomy by closure of mesenterial defects.
Table 5
Complications after RYGBP
Complication
Group 1 (N=74)
Group 2 (N=14)
Group 3 (N=13)
Total (N=101)
Anastomotic stenosis
10 (13.5%)
9 (64.3%)
4 (30.8%)
23 (22.7%)
Anastomotic leakage (operative)
2 (2.7%)
2 (14.3%)
0
4 (4.0%)
Anastomotic leakage (conservative)
2 (2.7%)
0
0
2 (2.0%)
Intraabdominal abscess
1 (1.4%)
1 (7.1%)
0
2 (2.0%)
Wound abscess
6 (8.1%)
1 (7.1%)
0
7 (7.0%)
Wound infection
1 (1.4%)
0
1 (7.7%)
2 (2.0%)
Urinary tract infection
3 (4.1%)
1 (7.1%)
2 (15.4%)
6 (6.0%)
Pneumonia
2 (2.7%)
0
0
2 (2.0%)
Incisional hernia
14 (18.9%)
1 (7.1%)
2 (15.4%)
17 (16.8%)
Internal herniation
1 (1.4%)
2 (14.3%)
1 (7.7%)
4 (4.0%)
Death
2 (2.7%)
0
0
2 (2.0%)

Minor Direct Postoperative Complications.

Wound abscess (7.0%), urinary tract infection (6.0%), pneumonia (2.0%) and wound infection (2.0%) were all treated without re-operation by antibiotics or abscess drainage on the surgical ward.

Long-term Complications.

During follow-up, anastomotic stenosis developed in 23 patients (22.7%). In group 2, 64.3% of the patients had anastomotic stenosis compared to 13.5% in group 1 and 30.8% in group 3. Since the introduction of the larger anastomosis with a silastic ring around the pouch (Fobi-Pouch22,23), a technique used in the last 13 patients, no more anastomotic stenosis have been observed. All stenoses were treated by endoscopic dilatation. The mean number of endoscopic dilatations was 2 ± 1 sessions, with a range of one to four sessions.
An incisional hernia was diagnosed in 17 patients (16.8%) during follow-up. Patients from group 1 had more incisional hernias (18.9%) compared to patients from group 2 (7.1%) and 3 (15.4%). All were treated by surgical correction using mesh repair.

Effect on Body Weight

Follow-up after conversion was achieved in all patients (100%), with a mean period of 38 ± 29 months. In group 2, the follow-up period was longer with 48 ± 34 months, compared to 39 ± 29 and 24 ± 20 months for group 1 and 3.
Group 1 had mean weight and BMI before VBG of 139 ± 28 kg and 49.6 ± 8.0 kg/m2, respectively (Table 6). These patients initially had successful weight loss after VBG. The lowest mean weight and BMI during follow-up was 84 ± 19 kg and 30.4 ± 6.5 kg/m2. Patients had weight regain leading to a mean weight and BMI of 113 ± 23 kg and 40.5 ± 7.1 kg/m2 before the conversion. RYGBP led to successful weight loss with a mean weight and BMI of 83 ± 23 kg and 30.1 ± 8.4 kg/m2, comparable to the maximum weight loss after VBG.
Table 6
Weight before VBG, and before and after RYGBP
 
Group 1 (N=74)
Group 2 (N=14)
Group 3 (N=13)
Total
Follow-up after RYGBP (months)
39 ± 29
48 + 34
24 ± 20
38 ± 29
Weight before VBG (kg)
139 ± 28
134 ± 27
127 ± 24
137 ± 27.5
BMI before VBG (kg/m2)
49.6 ± 8.0
45.1 ± 5.1
44.7 ± 6.8
48.4 ± 7.7
Weight before RYGBP (kg)
113 ± 23
69 ± 19.5
83 ± 24
-
BMI before RYGBP (kg/m2)
40.5 ± 7.1
22.3 ± 4.8
29.8 ± 7.9
-
Last weight (kg)
83 ± 23
75 ± 15
82 ± 17
-
Last BMI (kg/m2)
30.1 ± 8.4
25.3 ± 5.2
29.0 ± 5.0
-
Group 2 had a mean weight and BMI before VBG of 134 ± 27 kg and 45.1 ± 5.1 kg/m2, respectively. This group lost significant weight in a relatively short period. In order to prevent further weight loss and serious malnutrition, conversion to RYGBP was performed when weight and BMI were 69 ± 15 kg and 22.3 ± 4.8 kg/m2. After a mean follow-up period of 48 months, weight and BMI were increased and stabilized at 75 ± 15 kg and 25.3 ± 5.2 kg/m2.
Group 3 had mean weight and BMI before VBG of 127 ± 24 kg and 44.7 ± 6.8 kg/m2, respectively. RYGBP was performed to treat symptoms while weight loss was satisfactory after VBG (mean BMI of 29.8 ± 7.9 kg/m2). After conversion to RYGBP, weight and BMI remained stable at 82 ± 17 kg and 29.0 ± 5.0 kg/m2.

Effect on Co-morbidities

After VBG and before conversion to RYGBP, co-morbidities were already decreased because of the overall weight loss (Table 7). For example, diabetes had already resolved in 4 of the 5 patients and hypertension in 10 of the 22 patients. Parallel to the weight loss after conversion to RYGBP, obesity-related co-morbidities decreased further in group 1. There was a continuous decrease in co-morbidities after the conversion, but numbers are small because of the already substantial decrease after VBG. Diabetes and sleep apnea syndrome completely resolved after RYGBP, while hypertension, hypercholesterolemia, joint problems, asthmatic complaints, GERD and depression all improved further.
Table 7
Co-morbidities before VBG, and before and after RYGBP (group 1; N=74)
Comorbidity
Before VBG
Before RYGBP
After RYGBP
Diabetes
5 (6.8%)
1 (1.4%)
0 (0%)
Hypertension
22 (29.7%)
12 (16.2%)
2 (2.7%)
Hypercholesterolemia
5 (6.8%)
2 (2.7%)
1 (1.4%)
Sleep apnea syndrome
7 (9.5%)
2 (2.7%)
0 (0%)
Joint problems
41 (55.4%)
30 (40.5%)
13 (17.6%)
Asthmatic complaints
12 (16.2%)
7 (9.5%)
1 (1.4%)
GERD
13 (17.6%)
15 (20.3%)
8 (10.8%)
Depression
22 (29.7%)
20 (27.0%)
11 (14.9%)

Effect on Patients’ Symptoms

Patients from group 3 were specifically operated in order to treat symptoms caused by complications of VBG while weight loss was already satisfactory. All symptoms consisted of upper abdominal complaints: nausea, vomiting, pyrosis, gastric and eating pain, dysphagia and eating difficulties. The presence of symptoms before and after conversion to RYGBP is described in Table 8. All were significantly improved after the conversion.
Table 8
Symptoms before and after RYGBP (group 3; N=13)
Symptoms
Before RYGBP
After RYGBP
Nausea
6 (46.2%)
1 (7.7%)
Vomiting
12 (92.3%)
1 (7.7%)
Pyrosis
10 (76.9%)
2 (15.4%)
Gastric pain
7 (53.8%)
2 (15.4%)
Dysphagia
3 (23.1%)
1 (7.7%)
Pain (while eating)
7 (53.8%)
2 (15.4%)
Passage problem
13 (100%)
2 (15.4%)

Revisional Surgery after Conversion to RYGBP

Seven patients (6.9%) needed revisional surgery after conversion from VBG to RYGBP after a mean period of 32 months. All patients were from group 1. Five patients again developed a significant weight regain after initially successful weight loss. In four patients, three with staple-line disruption initially and one a sweets eater as the indication for conversion, the RYGBP was converted to a distal RYGBP with a common channel of 1–1.5 meters. In one patient with spinal cord injury and permanent immobility, an adjustable gastric band was placed around the gastric pouch in order to produce more weight loss but minimize the chance on diarrhea. One patient developed late internal herniation. During elective re-operation, 20 cm of jejunum was resected and a new gastrojejunostomy was created. The seventh patient complained of severe eating difficulties caused by anastomotic stenosis. After 3 endoscopic dilatations, the symptoms remained unchanged. During elective re-operation, a thorough adhesiolysis was performed and the anastomosis was disconnected and transected. A new and wider gastrojejunostomy was created. In the last three patients, the indication for conversion from VBG to RYGBP was pouch dilatation in one patient and staple-line disruption in two patients.

Discussion

After the introduction of the VBG,24 thousands of morbidly obese patients have been treated with this restrictive procedure. Long-term follow-up studies of VBG report a variable success rate in terms of maintenance of weight loss. Balsiger et al25 found a maintenance of at least 50% excess weight loss (%EWL) 10 years after VBG in only 26% of the patients, while Sugerman et al26 reported a %EWL 3 years after VBG of only 38%. The patients of van Dielen et al27 had a better %EWL of 70% after 1 year but the mean weight slightly increased again after 2 years. This observation of weight regain after initial successful weight loss is also reported by Nilsell et al.28 There are, however, reports that show much better results of VBG with weight control in 80% of patients without revisional surgery.29
Besides the variable success on weight loss in the long-term, a number of patients develop symptoms or complications after VBG that require revisional surgery. Well-known postoperative problems are frequent vomiting, GERD, maladaptive eating pattern leading to weight regain (“sweets eaters”) and food intolerance caused by the restriction.13,19,23 A report from Balsiger et al30 found GERD to rise from 15% preoperatively to 38% postoperatively. Furthermore, after a follow-up period of at least 10 years, 30% of patients had a maladaptive eating pattern while 22% had more than one vomiting episode per week.25
As a result of unsatisfactory weight loss and/or unacceptable side-effects and complications, revisional surgery after VBG is common. The reported incidence is 10% to 41%, but is strongly dependent on the duration and completeness of follow-up.1216
For revisional surgery after VBG, several options are available. A restoration of VBG (re-VBG) is the first option. However, reports have shown that this restoration is not always successful. Van Gemert et al17 reported that after re-VBG, using a Kaplan-Meyer analysis, 68% of the patients needed further revisional surgery because of complications or unsatisfactory weight loss. Other authors have reported similar poor results of re-VBG.18,20,3134
Another option is conversion to adjustable gastric banding (AGB). Taskin et al35 reported 7 patients who underwent this conversion and achieved satisfactory results, comparable with the results after primary AGB.35 However, because of the same restrictive nature of the procedure, complications like GERD and maladaptive eating patterns can prevail after the conversion. Additional data about the results of the conversion from VBG to AGB are not yet available.
Results of conversion from VBG to RYGBP are described more frequently. Sugerman et al18 reported on 53 patients where %EWL increased from 36% to 67% after the conversion. Results were even better in “sweets eaters”; %EWL increased from 20% to 70% in that patient group.18 Cordera et al19 reported a decrease in BMI with 46 kg/m2 before conversion and 35 kg/m2 after. Also, co-morbidities diminished and subjective patient satisfaction was 90%. Kfoury et al20 performed a distal RYGBP in 45 patients after failed VBG. Results after a follow-up period of at least 2 years were available for 29 patients and %EWL was 74% in this group.20 Gonzalez et al21 reported a decrease in BMI from 40 kg/m2 to 32 kg/m2 at 16 months postoperatively. Based on these literature findings, conversion to RYGBP seems to be the most successful treatment option for failed VBG, in terms of postoperative weight loss. However, our data show that the effect on weight is strongly dependent of the indication for the conversion. In patients with weight regain after initially successful VBG the mean BMI decreased from 40.5 ± 7.1 kg/m2 to 30.1 ± 8.4 kg/m2. In contrast, in patients who experienced excessive weight loss after VBG, a slight increase of BMI was observed, while in patients with acceptable weight loss but severe eating difficulties, the BMI remained stable. The latter group underwent the conversion specifically to treat symptoms caused by failed VBG. In the study by Sugerman et al,18 the conversion led to relief of symptoms in 23 patients with intractable vomiting or GERD.18 In the study by Kfoury et al,20 10 patients were included with symptoms of GERD; conversion led to a reduction of symptoms in all patients. Balsiger et al25 performed 25 conversions on patients with severe GERD after VBG. At follow-up after 37 months, all patients were free of symptoms.25 The results from our study support these literature findings: in group 3, all patients had severe eating difficulties after VBG along with a range of GI complaints. All symptoms significantly decreased after the conversion.
Other important aspects of revisional bariatric surgery are early and long-term morbidity and mortality, which tend to be higher than after primary bariatric surgery.21 Reported postoperative mortality after revisional bariatric surgery is 0–2%.20,3134,36,37 The overall morbidity rate is 12% to 41% and strongly dependent on the completeness and duration of follow-up.20,3134,36,37 In the present study, follow-up was 100% with a mean duration of 38 months. A low rate of perioperative complications was found (2% to 7%), but the long-term complications of anastomotic stenosis and incisional hernia occurred in 22.7% and 16.8%, respectively. This high incidence of long-term complications is, however, within the range of literature findings where anastomotic stenosis is observed in 4% to 38% and incisional hernia in 2% to 20%.12,1719,21,25
The number of hernias could decrease if the conversion from VBG to RYGBP is performed by laparoscopy. Gagner et al38 performed 24 laparoscopic gastric bypasses as a revisional procedure after failed bariatric surgery; 12 patients in this group had failed VBG. Results showed longer operation time but shorter hospital stay and a morbidity rate of 22%. Secondary revisional surgery was necessary in 14.8%. Reports by McCormick et al39 and de Csepel et al40 support these findings although their patient groups were small (N=5 and N=7). Future studies will have to discern whether laparoscopic revisional surgery after failed VBG is comparable to open revisional procedures in terms of results, safety and feasibility.
In conclusion, revisional bariatric surgery has a high risk of complications and this has to be considered by the surgical team before re-operation. Conversion from failed VBG to RYGBP is generally a successful operation. Results are strongly dependent of the indication for conversion, but the desired effect on weight and symptoms is achieved.
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License ( https://​creativecommons.​org/​licenses/​by-nc/​2.​0 ), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
1.
Zurück zum Zitat Martin LF, Hunter SM, Lauve RM et al. Severe obesity: expensive to society, frustrating to treat, but important to confront. South Med J 1995; 88: 895–02.CrossRefPubMed Martin LF, Hunter SM, Lauve RM et al. Severe obesity: expensive to society, frustrating to treat, but important to confront. South Med J 1995; 88: 895–02.CrossRefPubMed
2.
Zurück zum Zitat Drenick EJ. Definition and health consequences of morbid obesity. Surg Clin North Am 1979; 59: 963–6.PubMed Drenick EJ. Definition and health consequences of morbid obesity. Surg Clin North Am 1979; 59: 963–6.PubMed
3.
Zurück zum Zitat National Institutes of Health. The practical guide: identification, evaluation and treatment of overweight and obesity in adults. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute, and North American Association for the Study of Obesity, 2000. NIH publication number 00–084. National Institutes of Health. The practical guide: identification, evaluation and treatment of overweight and obesity in adults. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute, and North American Association for the Study of Obesity, 2000. NIH publication number 00–084.
4.
Zurück zum Zitat Kemper HCG, Stasse-Wolthuis M, Bosman W. The prevention and treatment of overweight and obesity. Summary of the advisory report by the Health Council of the Netherlands. Neth J of Med 2004; 62: 10–. Kemper HCG, Stasse-Wolthuis M, Bosman W. The prevention and treatment of overweight and obesity. Summary of the advisory report by the Health Council of the Netherlands. Neth J of Med 2004; 62: 10–.
5.
Zurück zum Zitat Fisher BL, Schauer P. Medical and surgical options in the treatment of severe obesity. Am J Surg 2002; 184: 9S–6S.CrossRefPubMed Fisher BL, Schauer P. Medical and surgical options in the treatment of severe obesity. Am J Surg 2002; 184: 9S–6S.CrossRefPubMed
6.
Zurück zum Zitat Bjorntorp P. Results of conservative therapy of obesity: correlation with adipose tissue morphology. Am J Clin Nutr 1980; 33: 370–.PubMed Bjorntorp P. Results of conservative therapy of obesity: correlation with adipose tissue morphology. Am J Clin Nutr 1980; 33: 370–.PubMed
7.
Zurück zum Zitat Printen KJ, Mason EE. Gastric surgery for relief of morbid obesity. Arch Surg 1973; 106: 428–1.PubMed Printen KJ, Mason EE. Gastric surgery for relief of morbid obesity. Arch Surg 1973; 106: 428–1.PubMed
8.
Zurück zum Zitat Gomez CA. Gastroplasty in the surgical treatment of morbid obesity. Am J Clin Nutr 1980; 33: 406–5.PubMed Gomez CA. Gastroplasty in the surgical treatment of morbid obesity. Am J Clin Nutr 1980; 33: 406–5.PubMed
9.
Zurück zum Zitat Mason EE, Doherty C, Cullen JJ. Vertical gastroplasty: evaluation of vertical banded gastroplasty. World J Surg 1998; 22: 919–4.CrossRefPubMed Mason EE, Doherty C, Cullen JJ. Vertical gastroplasty: evaluation of vertical banded gastroplasty. World J Surg 1998; 22: 919–4.CrossRefPubMed
10.
Zurück zum Zitat Eckhout GV, Willbanks OL, Moore JT. Vertical ring gastroplasty for morbid obesity: five year experience with 1463 patients. Am J Surg 1981; 141: 343–. Eckhout GV, Willbanks OL, Moore JT. Vertical ring gastroplasty for morbid obesity: five year experience with 1463 patients. Am J Surg 1981; 141: 343–.
11.
Zurück zum Zitat Deitel M, Shikora SA. The development of the surgical treatment of morbid obesity. J Am Coll Nutr 2002; 21: 365–1.PubMed Deitel M, Shikora SA. The development of the surgical treatment of morbid obesity. J Am Coll Nutr 2002; 21: 365–1.PubMed
12.
Zurück zum Zitat Maclean LD, Rhode BM, Forse RA. Late results of vertical banded gastroplasty for morbid obesity and super obesity. Surgery 1990; 107: 20–.PubMed Maclean LD, Rhode BM, Forse RA. Late results of vertical banded gastroplasty for morbid obesity and super obesity. Surgery 1990; 107: 20–.PubMed
13.
Zurück zum Zitat Arribas del Amo D, Martinez-Diaz M, Elia Guedea M et al. Vertical banded gastroplasty: is it a durable operation for morbid obesity? Obes Surg 2004; 4: 536–.CrossRef Arribas del Amo D, Martinez-Diaz M, Elia Guedea M et al. Vertical banded gastroplasty: is it a durable operation for morbid obesity? Obes Surg 2004; 4: 536–.CrossRef
14.
Zurück zum Zitat Naslund E, Backman L, Granstrom L et al. Seven year results of vertical banded gastroplasty for morbid obesity. Eur J Surg 1997; 163: 281–.PubMed Naslund E, Backman L, Granstrom L et al. Seven year results of vertical banded gastroplasty for morbid obesity. Eur J Surg 1997; 163: 281–.PubMed
15.
Zurück zum Zitat Hall JC, Watts JM, O’Brien PE et al. Gastric surgery for morbid obesity. The Adelaide study. Ann Surg 1990; 211: 419–.CrossRef Hall JC, Watts JM, O’Brien PE et al. Gastric surgery for morbid obesity. The Adelaide study. Ann Surg 1990; 211: 419–.CrossRef
16.
Zurück zum Zitat Gemert van WG, Greve JWM, Soeters PB. Long-term results of vertical banded gastroplasty: Marlex versus Dacron banding. Obes Surg 1997; 7: 128–5.CrossRefPubMed Gemert van WG, Greve JWM, Soeters PB. Long-term results of vertical banded gastroplasty: Marlex versus Dacron banding. Obes Surg 1997; 7: 128–5.CrossRefPubMed
17.
Zurück zum Zitat Gemert van WG, Wersch MM, Greve JWM et al. Revisional surgery after failed vertical banded gastroplasty: restoration of vertical banded gastroplasty or conversion to gastric bypass. Obes Surg 1997; 7: 1–. Gemert van WG, Wersch MM, Greve JWM et al. Revisional surgery after failed vertical banded gastroplasty: restoration of vertical banded gastroplasty or conversion to gastric bypass. Obes Surg 1997; 7: 1–.
18.
Zurück zum Zitat Sugerman HJ, Kellum JM, DeMaria EJ et al. Conversion of failed or complicated vertical banded gastroplasty to gastric bypass in morbid obesity. Am J Surg 1996; 171: 263–.CrossRefPubMed Sugerman HJ, Kellum JM, DeMaria EJ et al. Conversion of failed or complicated vertical banded gastroplasty to gastric bypass in morbid obesity. Am J Surg 1996; 171: 263–.CrossRefPubMed
19.
Zurück zum Zitat Cordera F, Mai JL, Thompson GB et al. Unsatisfactory weight loss after vertical banded gastroplasty: is conversion to Roux-en-y gastric bypass successful? Surgery 2004; 136: 731–.CrossRefPubMed Cordera F, Mai JL, Thompson GB et al. Unsatisfactory weight loss after vertical banded gastroplasty: is conversion to Roux-en-y gastric bypass successful? Surgery 2004; 136: 731–.CrossRefPubMed
20.
Zurück zum Zitat Kfoury E, Vanguiri A. Distal Roux-en-y gastric bypass conversion operation for failed vertical banded gastroplasty. Obes Surg 1993; 3: 41–.CrossRefPubMed Kfoury E, Vanguiri A. Distal Roux-en-y gastric bypass conversion operation for failed vertical banded gastroplasty. Obes Surg 1993; 3: 41–.CrossRefPubMed
21.
Zurück zum Zitat Gonzalez R, Gallagher SF, Haines K et al. Operative technique for converting a failed vertical banded gastroplasty to Roux-en-y gastric bypass. J Am Coll Surg 2005; 201: 366–4.CrossRefPubMed Gonzalez R, Gallagher SF, Haines K et al. Operative technique for converting a failed vertical banded gastroplasty to Roux-en-y gastric bypass. J Am Coll Surg 2005; 201: 366–4.CrossRefPubMed
22.
Zurück zum Zitat Fobi MA, Lee H. The surgical technique of the Fobi-Pouch operation for obesity. Obes Surg 1998; 8: 283–.CrossRefPubMed Fobi MA, Lee H. The surgical technique of the Fobi-Pouch operation for obesity. Obes Surg 1998; 8: 283–.CrossRefPubMed
23.
Zurück zum Zitat Fobi MAL, Lee H, Felahy B et al. Choosing an operation for weight control, and the transected banded gastric bypass. Obes Surg 2005; 15: 114–1.CrossRefPubMed Fobi MAL, Lee H, Felahy B et al. Choosing an operation for weight control, and the transected banded gastric bypass. Obes Surg 2005; 15: 114–1.CrossRefPubMed
24.
Zurück zum Zitat Mason EE. Vertical banded gastroplasty for obesity. Arch Surg 1982; 117: 701–.PubMed Mason EE. Vertical banded gastroplasty for obesity. Arch Surg 1982; 117: 701–.PubMed
25.
Zurück zum Zitat Balsiger BM, Poggio JL, Mai J et al. Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. J Gastrointest Surg 2000; 4: 598–05.CrossRefPubMed Balsiger BM, Poggio JL, Mai J et al. Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. J Gastrointest Surg 2000; 4: 598–05.CrossRefPubMed
26.
Zurück zum Zitat Sugerman HJ, Starkey JV, Birkenhauer R. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 1987; 205: 613–4.CrossRefPubMed Sugerman HJ, Starkey JV, Birkenhauer R. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 1987; 205: 613–4.CrossRefPubMed
27.
Zurück zum Zitat Dielen FMH van, Soeters PB, Brauw LM de et al. Laparoscopic adjustable gastric banding versus open vertical banded gastroplasty. A prospective randomized trial. Obes Surg 2005; 15: 1292–.CrossRefPubMed Dielen FMH van, Soeters PB, Brauw LM de et al. Laparoscopic adjustable gastric banding versus open vertical banded gastroplasty. A prospective randomized trial. Obes Surg 2005; 15: 1292–.CrossRefPubMed
28.
Zurück zum Zitat Nilsell K, Thorne A, Sjostedt S et al. Prospective randomized comparison of adjustable gastric banding and vertical banded gastroplasty for morbid obesity. Eur J Surg 2001; 167: 504–.CrossRefPubMed Nilsell K, Thorne A, Sjostedt S et al. Prospective randomized comparison of adjustable gastric banding and vertical banded gastroplasty for morbid obesity. Eur J Surg 2001; 167: 504–.CrossRefPubMed
29.
Zurück zum Zitat Mason EE. Gastric surgery for morbid obesity. Surg Clin North Am 1992; 72: 501–3.PubMed Mason EE. Gastric surgery for morbid obesity. Surg Clin North Am 1992; 72: 501–3.PubMed
30.
Zurück zum Zitat Balsiger BM, Murr MM, Mai J et al. Gastroesophageal reflux after intact vertical banded gastroplasty: correction by conversion to Roux-en-y gastric bypass. J Gastrointest Surg 2000; 4: 276–1.CrossRefPubMed Balsiger BM, Murr MM, Mai J et al. Gastroesophageal reflux after intact vertical banded gastroplasty: correction by conversion to Roux-en-y gastric bypass. J Gastrointest Surg 2000; 4: 276–1.CrossRefPubMed
31.
Zurück zum Zitat Sugerman HJ, Wolper JL. Failed gastroplasty for morbid obesity. Revised gastroplasty versus Roux-y gastric bypass. Am J Surg 1984; 148: 331–.CrossRefPubMed Sugerman HJ, Wolper JL. Failed gastroplasty for morbid obesity. Revised gastroplasty versus Roux-y gastric bypass. Am J Surg 1984; 148: 331–.CrossRefPubMed
32.
Zurück zum Zitat Benotti PN, Forse RA. Safety and long-term efficacy of revisional surgery in severe obesity. Am J Surg 1996; 172: 232–.CrossRefPubMed Benotti PN, Forse RA. Safety and long-term efficacy of revisional surgery in severe obesity. Am J Surg 1996; 172: 232–.CrossRefPubMed
33.
Zurück zum Zitat Linner JH, Drew RL. Reoperative surgery - indications, efficacy, and long-term follow-up. Am J Clin Nutr 1992; 55: 606S–10S.PubMed Linner JH, Drew RL. Reoperative surgery - indications, efficacy, and long-term follow-up. Am J Clin Nutr 1992; 55: 606S–10S.PubMed
34.
Zurück zum Zitat Behrns KE, Smith CD, Kelly KA et al. Reoperative bariatric surgery. Lessons learned to improve patient selection and results. Ann Surg 1993; 218: 646–3.CrossRefPubMed Behrns KE, Smith CD, Kelly KA et al. Reoperative bariatric surgery. Lessons learned to improve patient selection and results. Ann Surg 1993; 218: 646–3.CrossRefPubMed
35.
Zurück zum Zitat Taskin M, Zengin K, Unal E et al. Conversion of failed vertical banded gastroplasty to open adjustable gastric banding. Obes Surg 2001; 11: 731–.CrossRefPubMed Taskin M, Zengin K, Unal E et al. Conversion of failed vertical banded gastroplasty to open adjustable gastric banding. Obes Surg 2001; 11: 731–.CrossRefPubMed
36.
Zurück zum Zitat Yale CE. Conversion surgery for morbid obesity: complications and long-term weight control. Surgery 1989; 106: 474–0.PubMed Yale CE. Conversion surgery for morbid obesity: complications and long-term weight control. Surgery 1989; 106: 474–0.PubMed
37.
Zurück zum Zitat Cates JA, Drenick EJ, Abedin MZ et al. Reoperative surgery for the morbidly obese. A university experience. Arch Surg 1990; 125: 1400–.PubMed Cates JA, Drenick EJ, Abedin MZ et al. Reoperative surgery for the morbidly obese. A university experience. Arch Surg 1990; 125: 1400–.PubMed
38.
Zurück zum Zitat Gagner M, Gentileschi P, Csepel J de. Laparoscopic reoperative bariatric surgery: experience from 27 consecutive patients. Obes Surg 2002: 12: 254–0.CrossRefPubMed Gagner M, Gentileschi P, Csepel J de. Laparoscopic reoperative bariatric surgery: experience from 27 consecutive patients. Obes Surg 2002: 12: 254–0.CrossRefPubMed
39.
Zurück zum Zitat McCormick JT, Papasavas PK, Caushaj PF et al. Laparoscopic revision of failed open bariatric procedures. Surg Endosc 2003; 17: 413–.CrossRefPubMed McCormick JT, Papasavas PK, Caushaj PF et al. Laparoscopic revision of failed open bariatric procedures. Surg Endosc 2003; 17: 413–.CrossRefPubMed
40.
Zurück zum Zitat Csepel J de, Nahouraii R, Gagner M. Laparoscopic gastric bypass as a reoperative bariatric surgery for failed open restrictive procedures. Surg Endosc 2001; 15: 393–.CrossRefPubMed Csepel J de, Nahouraii R, Gagner M. Laparoscopic gastric bypass as a reoperative bariatric surgery for failed open restrictive procedures. Surg Endosc 2001; 15: 393–.CrossRefPubMed
Metadaten
Titel
Conversion of Vertical Banded Gastroplasty to Roux-en-Y Gastric Bypass Results in Restoration of the Positive Effect on Weight Loss and Co-morbidities: Evaluation of 101 Patients
verfasst von
Ruben Schouten, MD
Francois M. H. van Dielen, MD, PhD
Wim G. van Gemert, MD, PhD
Jan Willem M. Greve, MD, PhD
Publikationsdatum
01.05.2007
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 5/2007
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-007-9106-2

Weitere Artikel der Ausgabe 5/2007

Obesity Surgery 5/2007 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.